Monday, November 06, 2023 8:17:40 AM
Good morning $NSAV shareholders. Our sincere apologies for not getting back to you Friday afternoon with an update on TruSAF. The update was that the details of the TruSAF IPO would be released this week.
— NSAV Holding (@NSAV_Tech) November 6, 2023
https://t.co/JVv7pgycez
We believe that all $NSAV shareholders will be pleased with what's coming next with TruSAF.https://t.co/JVv7pgycez
— NSAV Holding (@NSAV_Tech) November 6, 2023
As for the delay in Friday's TruSAF update, we had to take care of some accounting issues in preparation of $NSAV's Q3 2023 OTC Markets filings, which are due next week.
— NSAV Holding (@NSAV_Tech) November 6, 2023
In addition, following what we thought were very informative and positive tweets on Thursday and Friday, which were not as well received by the market as we expected, many $NSAV shareholders contacted us and we felt the need to reply and instill some much needed confidence.
— NSAV Holding (@NSAV_Tech) November 6, 2023
$NSAV management realizes that the Company is facing many challenges, as most OTC companies are today, but as always, we are here battling for our shareholders and that will never change.
— NSAV Holding (@NSAV_Tech) November 6, 2023
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM